Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C39H62O14 |
| Molecular Weight | 754.9012 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 22 / 22 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@H]5C[C@H](CC[C@]5(C)[C@H]4C(=O)C[C@]23C)O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)O[C@]18CC[C@@H](C)CO8
InChI
InChIKey=VWMZIGBYZQUQOA-QEEMJVPDSA-N
InChI=1S/C39H62O14/c1-17-7-10-39(48-16-17)18(2)27-24(53-39)12-22-21-6-5-19-11-20(8-9-37(19,3)28(21)23(42)13-38(22,27)4)49-35-33(47)31(45)34(26(15-41)51-35)52-36-32(46)30(44)29(43)25(14-40)50-36/h17-22,24-36,40-41,43-47H,5-16H2,1-4H3/t17-,18+,19+,20+,21+,22+,24+,25-,26-,27+,28-,29-,30+,31-,32-,33-,34-,35-,36+,37+,38+,39-/m1/s1
| Molecular Formula | C39H62O14 |
| Molecular Weight | 754.9012 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 22 / 22 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pamaqueside. CP 148623. | 2002 |
|
| Metabolism of pamaqueside, a cholesterol absorption inhibitor, in Long-Evans rat: effect of bile duct cannulation on absorption. | 1999-10 |
|
| 11-Ketotigogenin cellobioside (pamaqueside): a potent cholesterol absorption inhibitor in the hamster. | 1996-05-10 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:01:15 GMT 2025
by
admin
on
Mon Mar 31 18:01:15 GMT 2025
|
| Record UNII |
L1Y3WKM9WU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7440
Created by
admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
|
PRIMARY | |||
|
C099629
Created by
admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
|
PRIMARY | |||
|
L1Y3WKM9WU
Created by
admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
|
PRIMARY | |||
|
SUB09594MIG
Created by
admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
|
PRIMARY | |||
|
150332-35-7
Created by
admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
|
PRIMARY | |||
|
100000082782
Created by
admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
|
PRIMARY | |||
|
GG-90
Created by
admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
|
PRIMARY | |||
|
9918516
Created by
admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
|
PRIMARY | |||
|
C170284
Created by
admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
|
PRIMARY | |||
|
DTXSID001350961
Created by
admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
|
PRIMARY | |||
|
CHEMBL505268
Created by
admin on Mon Mar 31 18:01:15 GMT 2025 , Edited by admin on Mon Mar 31 18:01:15 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->INHIBITOR OF ABSORPTION |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|